Characterization and prevalence of severe primary IGF1 deficiency in a large cohort of French children with short stature

Abstract

The prevalence of severe primary IGFD defined using the standard criterion for rhIGF1 treatment was 1.2%, and only 0.2% of patients were eligible for rhIGF1 therapy.